Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 15
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase III Compazine vs Methadone vs Tetrahydrocannabinol vs Placebo in Patients Receiving ADR for Malignant Neoplasms
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Supportive care
Completed
no age specified
MAYO-818304
NCCTG-818304, NCI-W82-1092, W82-1092
Last Modified:
12/4/2006
 
First Published:
7/1/2001
2.
Phase III Randomized Study of 3 Regimens For the Prevention of Delayed Nausea After Chemotherapy in Patients With Chemotherapy-Naive Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Completed
18 and over
NCI
URCC-U3901
NCI-P01-0180, NCT00020657
3.
Phase I/II Chemotherapy with Intracarotid CACP/BLEO in Adults with Unresectable Intracerebral Neoplasms
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
over 15
MDA-DM-8459
NCI-V85-0016
Last Modified:
11/1/2001
 
First Published:
11/1/2001
4.
Phase II Randomized Study of High-Dose Metoclopramide for Doxorubicin and Cyclophosphamide-Induced Nausea and Vomiting in Patients With Soft Tisuue Sarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care, Treatment
Completed
18 and over
NCI
NCI-83-C-72
NCI-T83-1453
Last Modified:
3/1/1990
5.
Phase II Study of DOX Potentiation with Prochlorperazine in Patients with Advanced Breast Cancer (Summary Last Modified 03/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
SCCC-8944
NCI-V89-0302
Last Modified:
4/27/2007
6.
Phase II Pilot Study of DOX and Prochlorperazine in Patients with Renal Cell Carcinoma (Summary Last Modified 08/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 18
SCCC-91138
NCI-V92-0061
Last Modified:
8/1/1995
7.
Phase II Study of DOX with the Cellular Efflux Blocking Agent Prochlorperazine in Advanced Lung Cancer (Summary Last Modified 08/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 18
SCCC-91137
NCI-V92-0062
Last Modified:
5/1/1998
8.
Phase II Study of DOX/Prochlorperazine in Patients with Malignant Mesothelioma (Summary Last Modified 05/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 18
Other
SCCC-9072
NCI-V92-0063
Last Modified:
12/1/1993
9.
Phase II Study of Single-Dose Intravenous Ondansetron/Dexamethasone to Control Acute Vomiting Followed by Oral Dexamethasone/Prochlorperazine to Control Delayed Vomiting in Patients Receiving High-Dose Doxorubicin (Summary Last Modified 12/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Completed
18 and over
MSKCC-93098
NCI-V93-0318
Last Modified:
7/1/1997
10.
Phase I Study of Biochemical Modulation of Carboplatin/Etoposide by Dipyridamole/Prochlorperazine/Cyclosporine in Advanced or Refractory Cancer (Summary Last Modified 07/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 to physiologic 70
NCI
CHNMC-IRB-91149
NCI-V96-1029
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute